|

Pulmonary and Total Blood Volume in COPD

RECRUITINGSponsored by Copenhagen University Hospital, Rigshospitalet
Actively Recruiting
SponsorCopenhagen University Hospital, Rigshospitalet
Started2025-09-15
Est. completion2026-12-20
Eligibility
Age45 Years – 80 Years
Healthy vol.Accepted

Summary

Background Patients with chronic obstructive lung disease (COPD) suffer from a progressive loss of lung function that leads to poor quality of life, and often invalidity and early death. This is markedly affected by a reduced exercise capacity and dyspnoea, but the underlying mechanisms are unknown. In the present study, we aim to investigate whether this may involve a reduced pulmonary blood volume secondarily to a reduced total blood volume. Methods Design: Prospective matched comparative study Intervention: None Outcomes: The primary outcome is pulmonary blood volume estimated to total blood volume ratio between patients with COPD and healthy controls individually matched for age, sex, and height. Statistical design: All statistical analyses will be performed using R statistical software version 4.1.1 (R Project for Statistical Computing) within RStudio statistical software version 1.4.1717 (RStudio), and a two-tailed p\<0.05 will be considered statistically significant. Inspection of normality and variance homogeneity will be done by creating qq-plots and histogram. Regulatory considerations: This study will be submitted for approval by Regional Ethical Committee. Perspective: This study will help uncover fundamental aspects of the pathophysiology of COPD.

Eligibility

Age: 45 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Inclusion criteria -patients

  * Men and women
  * 45-80 years
  * COPD (GOLD stage I to III)
  * Resting arterial oxygenation \> 90% Inclusion criteria - controls
  * Men and women
  * 45-80 years
  * Normal FEV1, FVC, FEV1/FVC, and single-breath diffusion capacity
  * Same sex, age (± 3 years) and height (± 5 cm) as an included COPD patient
  * Low- to moderate activity level defined as \< 1,5 hours of structured physical activity pr. week at moderate intensity and cycling \< 30 minutes/5km pr. day at moderate intensity (moderate intensity = out of breath but able to speak)

Exclusion Criteria:

Exclusion criteria - patients

* Symptoms of ischaemic heart disease
* Known heart failure
* Previous severe or current COVID-19
* Claudication
* Symptoms of disease within 2 weeks prior to the study
* Participation in pulmonary rehabilitation within 6 months
* Known malignant disease
* Pregnancy
* Unstable cardiac arrhythmic disease
* Renal or liver dysfunction

Exclusion criteria - controls

* Known chronic lung disease
* Known ischaemic heart disease
* Known heart failure
* Previous severe or current COVID-19
* Symptoms of disease within 2 weeks prior to the study
* Known malignant disease
* Claudication
* Pregnancy
* Unstable cardiac arrhythmic disease
* Renal or liver dysfunction

Conditions3

COPDCOPD - Chronic Obstructive Pulmonary DiseaseHealthy Subjects

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.